To the Editor,
The 2019 novel coronavirus (2019-nCoV, COVID-19) has spread in nearly 100 countries, infected 217,645 patients, and resulted in 8942 deaths worldwide. The major clinical feature is Respiratory Distress Syndrome and one key complication is Acute Cardiac Injury [1]. Interestingly, a recent article of IJC may provide a clue to heart protection for COVID-19-infected individuals, based on the oxidative stress theory [2].
According to recent clinical reports, the therapeutic time for COVID-19 infection is much longer than 14 days, but long-time viral stimulation is prone to suddenly elicit intensive immunological reactions, cytokine storm and immune-cell infiltration in vivo; however, some immunocytes especially macrophages and neutrophils can produce numerous reactive oxygen species (ROS) including H2O2, (·O2 −), (·OH), etc. [[2], [3], [4]].
Generally, a certain level of ROS is important for regulating immunological responses and for clearing viruses, but excessive ROS will oxidize cellular proteins and membrane lipids and quickly destroy not only virus-infected cells but also normal cells in lung and even heart, resulting in multiple organ failure.
Thus, a potential anti-oxidative therapy could be proposed to alleviate cardiogenic casualties caused by COVID-19. Inexpensive medicinal antioxidants include Vitamin C (ascorbic acid) and Vitamin E, because their reductive hydrogen atoms can react with ROS and then produce nontoxic water [5]. Plant-derived molecules (similar to ancient Chinese medicine), such as Curcumin and Baicalin, may have potential anti-oxidative efficacy, too.
Predictably, a proper dose of antioxidants may ameliorate cardiac injuries of critically ill COVID-19-infected patients (but possibly not including mild-symptom patients).
Statement of authorship
The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.
Declaration of competing interest
None.
Acknowledgments
Hebei Provincial Social Science Fund Project (No. HB19SH020).
Footnotes
Supplementary data to this article can be found online at https://doi.org/10.1016/j.ijcard.2020.04.009.
Appendix A. Supplementary data
Supplementary material
References
- 1.Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China, Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Loffredo L., Martino F., Zicari A.M., Carnevale R., Battaglia S., Martino E. Enhanced NOX-2 derived oxidative stress in offspring of patients with early myocardial infarction. Int. J. Cardiol. 2019;293:56–59. doi: 10.1016/j.ijcard.2019.05.014. [DOI] [PubMed] [Google Scholar]
- 3.Perrone L.A., Belser J.A., Wadford D.A., Katz J.M., Tumpey T.M. Inducible nitric oxide contributes to viral pathogenesis following highly pathogenic influenza virus infection in mice. J. Infect. Dis. 2013;207:1576–1584. doi: 10.1093/infdis/jit062. [DOI] [PubMed] [Google Scholar]
- 4.Imai Y., Kuba K., Neely G.G., Yaghubian-Malhami R., Perkmann T., van Loo G. Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008;133:235–249. doi: 10.1016/j.cell.2008.02.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Erol N., Saglam L., Saglam Y.S., Erol H.S., Altun S., Aktas M.S. The protection potential of antioxidant vitamins against acute respiratory distress syndrome: a rat trial. Inflammation. 2019;42:1585–1594. doi: 10.1007/s10753-019-01020-2. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplementary material